Gene change inhibits tamoxifen -- study
16th Dec 2005, 19:58 GMT
A common breast cancer drug, tamoxifen, may not work as well in women with an inherited gene variation.
Gene change inhibits tamoxifen -- study related news:
- Gene undermines effectiveness of tamoxifen — United Press International - NewsTrack
- Gene Variation May Affect Tamoxifen Benefit — MedPage Today Public Health & Policy
- Mayo Clinic reports tamoxifen benefit for breast-cancer patients tied to inherited gene — EurekAlert! - Cancer
- Food Additive, Dihydrocoumarin, Inhibits Longevity Enzyme In Yeast, Increases Cell Toxicity, New Study Finds — Medical News Today RSS/XML Feed
- Survivor gene 'fights infection' — BBC News | UK | World Edition
- Tamoxifen May Boost Short Boys' Height — WebMD Health Headlines
- Scientists Identify Gene for Light Skin Color — TechNewsWorld
- Food additive inhibits longevity enzyme in yeast, increases cell toxicity, new study finds — EurekAlert! - Breaking News
- Switching to Anastrozole After Tamoxifen May Improve Overall Survival in Breast Cancer — Medscape Pharmacist Headlines
- Gene effects benefit of breast-cancer drug — KeralaNext: Health
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries